BlackRock, Inc.

13F Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 958K shares
Security Ownership: 1.8%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

2025-07-16 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 958K shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX). This represents 1.8% percent ownership of the company. In their previous filing dated 2025-04-24, BlackRock, Inc. had reported owning 2.83M shares, indicating a decrease of -66.1% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	1.8%	-72%	$1.27M	958K	-1,867,450	-66.1%	$1.33	13G/A	6/30/2025	16 Jul 2025 19:02:18
BlackRock, Inc.	5.4%		$3.59M	2.83M			$1.27	13G/A	3/31/2025	24 Apr 2025 09:12:39

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$3.72M	2.57M	-2,312,309	-47.4%	$1.45	Q2 2025
3/31/2025	0%	0%	$6.73M	4.88M	-82,867		$1.38	Q1 2025
12/31/2024	0%	+0%	$15.1M	4.96M	+328,824	+7.1%	$3.04	Q4 2024
9/30/2024	0%		$23.1M	4.63M			$4.98	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.